Long-actingβ₂-agonists are recommended as monotherapy for asthma.Long-actingβ₂-agonists may be recommended as monotherapy for patients with chronic obstructive pulmonary disease (COPD) who have moderate to severe airflow obstruction.
A) Both statements are true.
B) Both statements are false.
C) The first statement is true,the second is false.
D) The first statement is false,the second is true.
Correct Answer:
Verified
Q50: Why should intranasal decongestants only be used
Q51: Which type of drug is used in
Q52: Why is phenylephrine being used in many
Q53: Which of the following are sources of
Q54: Which respiratory disease is characterized by destruction
Q56: Asthma is characterized by _ airway obstruction,and
Q57: Oral decongestants should be used with caution
Q58: Researchers have suggested that oxygen be limited
Q59: Oral decongestants are alpha-adrenergic antagonists that cause
Q60: Which is an interleukin-5 antibody antagonist?
A)Montelukast (Singulair)
B)Mepolizumab
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents